Skip left side navigation and go to content NHLBI AND THE RECOVERY ACT
featured scientist featured scientist featured scientist featured scientist


Pamela L. Zeitlin, M.D., Ph.D.

I am Dr. Pamela Zeitlin and I am a Professor of Pediatrics at the Johns Hopkins Childrens Center at the Johns Hopkins Hospital in Baltimore, Maryland.

My research is directed at a disease called Cystic Fibrosis. My primary NIH grant is looking at an alternative gene as a treatment target for the disease CF.

This stimulus money is very specifically focused on basic research in the laboratory, but it is translated very quickly in my research group to clinical trials. So we are much closer to a clinical trial with an investigational molecule directed at this alternative channel than we were without the stimulus funding. So I am hoping to accelerate the pace of finding a clinical treatment for CF.


Pamela L. Zeitlin, M.D., Ph.D.
Professor, Johns Hopkins University, Baltimore, Maryland
Student and/or teacher summer research experiences
Administered by the NHLBI Division of Lung Diseases, Airway Biology and Disease Branch
FY 2009 Recovery Act Funding: $67,043

Last Updated:September 4, 2009


Important Links
Information from the White House and President Obama

Recovery Information from Health and Human Services

NIH's Role in ARRA

NIH's Recovery Site

Inspector General (IG)


E-Newsletter Sign-Up
Interested in Recovery Act
information? Join the NHLBI Research and Policy Update listserv to receive The NHLBI’s Recovery Act News e-newsletter and other updates. Join the listserv.

Share Your Recovery Act Story
Please send us an e-mail.